MedPath

Clinical study evaluates the safety and efficacy of the OA Kneetrac CHANGEUI MEDICAL co., Ltd. for patients with knee joint osteoarthritis

Not Applicable
Recruiting
Conditions
Diseases of the musculo-skeletal system and connective tissue
Registration Number
KCT0002179
Lead Sponsor
Chonbuk National University Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
40
Inclusion Criteria

1) Adults over 20 years old
2) Diagnosis: Osteoarthritis of the Knee
3) In the anteroposterior x-ray of the knee in a standing position according to the scale Kellgren-Lawrence (K-L) patient received ?, ? grade diagnosis
4) The patient has subscribed the informed consent

Exclusion Criteria

1) The patients with lower extremity surgical treatments and cortisone injections for those who receive treatment within the last 3 months. (Steroidal and non-steroidal anti-inflammatory drug treatments, such as drugs does not limit)
2) The patients with ligaments injury, knee joint infection, inflammatory joint disease, fibromyalgia, symptoms of nerve root compression in the spine, central nervous system diseases, polyneuropathy, cognitive disorders, etc.
3) Principal investigator who is deemed unsuitable for clinical trial participation

Study & Design

Study Type
Interventional Study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
WOMAC score(Western Ontario and McMaster Universities Arthritis Index)
Secondary Outcome Measures
NameTimeMethod
Quality of Life SF-36(Short Form-36);VAS(Visual Analog Scale);Bio-dex
© Copyright 2025. All Rights Reserved by MedPath